Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Nicolas Garel

Assistant Professor

Université de Montréal

Canada

Research Interests

Explore related searches

Professors in Canada

Articles (12)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (6)

Jean-Sebastien Fallu

Professor (full)

Université de Montréal

CANADA

View details

Michel Dorval

CANADA

View details

Didier Jutras-Aswad

Professeur titulaire

Université de Montréal

CANADA

View details

David Erritzoe

• Clinical Associate Professor in Neuropsychopharmacology and Psychiatry

Imperial College London

UNITED KINGDOM

View details

Gustavo Turecki

Chair

McGill University

CANADA

View details

Jean-Philippe Miron

Assistant Clinical Professor

University of California, San Diego

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicolas Garel

Research Interests

Explore related searches

Articles (12)

From regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapy

Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders

The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression

Cognitive effects of intravenous Ketamine in treatment-resistant depression: A systematic review

Measuring the psychoactive effects of ketamine in alcohol use disorder: When assessment shapes experience

The promise and challenges of psychedelic-assisted therapy: lessons from Canada’s Special Access Program

Elevated allostatic load is associated with poorer response to repetitive transcranial magnetic stimulation in treatment-resistant depression

Nicolas Garel: Combining psychoactive molecules and psychotherapy for patients suffering from mood and substance use disorders: a new therapeutic paradigm

Advancing research: a commentary on the untapped potential of acceptance and commitment therapy in alcohol use disorder treatment

Trends in hallucinogen‐associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022

Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report

Collaborators (6)

Jean-Sebastien Fallu

Michel Dorval

Didier Jutras-Aswad

David Erritzoe

Gustavo Turecki

Jean-Philippe Miron

Make your next move.